Sidd Shrivastava, PhD

Bio:

Sidd is Senior Vice President, Head of CMC and Global Operations at Cue Biopharma, where he leads enterprise-wide integration of science, operations, and strategy to advance cutting-edge immunotherapies in oncology and autoimmune disease. With over two decades of experience, he has been associated with T-cell therapy, more than 35 biologics and 200+ small molecules, securing 28 regulatory approvals while leading programs from concept to global launches and relaunches. A recognized industry leader, Dr. Shrivastava is known for building high-performance, multisite organizations transforming technical operations, forging strategic partnerships, and delivering innovative manufacturing and CMC solutions that accelerate speed to clinic while ensuring quality and compliance.